| Size & multiples | |||
| Market Cap | $12.44B | Enterprise Value | $14.74B |
| P/E (TTM) | 53.87× | PEG (trailing) | — |
| P/S | 4.29× | P/FCF | 25.25× |
| EV/EBITDA | 19.06× | EV/EBIT | 40.91× |
| EV/Sales | 5.08× | EV/FCF | 29.92× |
| FCF Yield | 3.96% | Buyback Yield | 6.06% |
| Owner Earnings (TTM) | $575.3M | Owner Earnings Yield | 4.62% |
| Shareholder Yield | 6.32% | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.10 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 9.52% |
| After-tax Cost of Debt | 2.61% | Synthetic credit rating | A- |
| Cost of Debt · embedded (pre-tax) | 2.92% | Cost of Debt · marginal (synthetic) | 4.89% |
| WACC | 8.10% | ROIC | 3.32% |
| EVA Spread (ROIC−WACC) | −4.78% | EVA | -$456.5M |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $2.07 · revenue TTM $2.90B · FCF TTM $492.7M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Rich vs Health Care on P/E, EV/EBITDA
P/E 84th · EV/EBITDA 66th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 53.9x | 24.4x | 13.0x–39.3x | 84 ↑rich |
| EV/EBITDA | 19.3x | 15.1x | 9.8x–24.4x | 66 ↑rich |
| FCF Yield | 4.1% | -7.8% | -34.7%–1.4% | 84 ↑strong |
| Dividend Yield | 0.3% | 1.1% | 0.2%–2.4% | 29 ↓weak |
| Net Margin | 8.4% | -21.2% | -325.3%–7.2% | 77 ↑strong |
| Operating Margin | 12.5% | -34.5% | -552.0%–8.0% | 81 ↑strong |
| ROE | 3.2% | -36.8% | -92.5%–4.5% | 74 ↑strong |
